scispace - formally typeset
L

Lakhbir Sandhu

Researcher at University of Toronto

Publications -  7
Citations -  8126

Lakhbir Sandhu is an academic researcher from University of Toronto. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 4, co-authored 5 publications receiving 4297 citations.

Papers
More filters
Journal ArticleDOI

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

TL;DR: Risk of Bias In Non-randomised Studies - of Interventions is developed, a new tool for evaluating risk of bias in estimates of the comparative effectiveness of interventions from studies that did not use randomisation to allocate units or clusters of individuals to comparison groups.
Journal ArticleDOI

Living vs. deceased donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis.

TL;DR: Evidence of lower DFS after LDLT compared with DDLT for HCC is provided, and improved study design and reporting is required in future research to ascribe the observed difference in DFS to study bias or biological risk specifically associated with LDLT.
Journal ArticleDOI

Assessing the management of hepatic colorectal cancer metastases: is treatment consistent in Ontario?

TL;DR: Notable heterogeneity was observed among Ontario's HPB surgeons in approaches to HCCM and preoperative portal vein embolization was favoured over RFA in patients with a small metastasis and inadequate functional hepatic volume.
Journal ArticleDOI

Contralateral prophylactic mastectomy rate stable at major Canadian breast cancer center

TL;DR: CPM rates from 2004 to 2010 at a high-volume Canadian breast cancer center did not increase over time, in contrast to trends observed in the United States.
Journal ArticleDOI

Bias estimation in study design: a meta-epidemiological analysis of transcatheter versus surgical aortic valve replacement.

TL;DR: Study design attributes related to the completeness of follow-up may explain biased treatment estimates in nonrandomized studies, as in the case of aortic valve replacement where high-risk patients were preferentially selected for the newer (transcatheter) procedure.